In June, Medtronic stopped distributing and selling its HeartWare Ventricular Assist Device (HVAD) system amid a slew of clinical comparisons indicating a higher frequency of neurological adverse events, including stroke and mortality, with the HVAD system. The company had previously recalled the device after 855 complaints and eight injuries related to an issue with the device’s ports in February. Medtronic reported 12 deaths among implanted patients in that recall, although three weren’t related to the particular issue at hand.
Get the full story at our sister site, Medical Design & Outsourcing.